ENTITY

Immunovant Inc (IMVT US)

Analysis

Health Care • United States

Immunovant Inc operates as a biopharmaceutical company. The Company offers discovers and manufactures drugs for patients with autoimmune diseases. Immunovant serves customers worldwide.

Refresh

Focused

No publications yet

There aren’t any buy-side reports right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00